DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients
Status:
Terminated
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out what the response is and the side effects are with
chemotherapy using a combination of drugs called D.T. PACE (Dexamethasone, Thalidomide,
cis-Platinum, Adriamycin, Cyclophosphamide, and Etoposide) + Rituxan, followed by two
autologous transplants.